SCHEMBL6710352

SCHEMBL6710352

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4cccs4)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
KDM4E B2RXH2 6/20 0.42
TYMS P04818 1/20 0.38
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
POLB P06746 4/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 2/20 0.36
BLM P54132 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
THRB P10828 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
GAPDH P04406 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7199402 0.89 STK33 (0.40) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6713576 0.89 MAPT (0.43) MAPTKDM4ETYMSKMT2AMEN1
SCHEMBL6709207 0.89 PARP14 (0.43) KDM4ETYMSALDH1A1PARP14LMNA
SCHEMBL6713921 0.89 MAPT (0.43) MAPTKDM4ETYMSKMT2AMEN1
SCHEMBL6709008 0.88 MAPT (0.36) MAPTALDH1A1POLBTDP1ALOX15
SCHEMBL6710395 0.88 PKM (0.35) MAPTPOLBTDP1THRBPARP14
SCHEMBL6710251 0.87 PARP14 (0.35) POLBPARP14LMNA
SCHEMBL6713683 0.87 PARP14 (0.37) MAPTPARP14
SCHEMBL6710454 0.87 PARP14 (0.41) MAPTKMT2AMEN1POLBNPC1
SCHEMBL6707895 0.87 PARP14 (0.39) MAPTKDM4ETYMSKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885KDM4E 1582/4885TYMS 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.